U.S. Clinical Laboratory Tests Market Size, Share, Trends, & Industry Analysis Report By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), and By End Use – Market Forecast, 2025–2034

The U.S. clinical laboratory tests market size is expected to reach USD 95.24 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Clinical Laboratory Tests Market Share, Size, Trends, Industry Analysis Report: By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical laboratory tests are defined as critical diagnostic evaluations that aid physicians in detecting, monitoring, and managing a wide range of health conditions. The U.S. clinical laboratory tests market is driven by the integration of advanced diagnostic technologies, which have enhanced the precision, speed, and accessibility of testing services. Innovations such as molecular assays, next-generation sequencing, and automation have transformed traditional laboratory workflows, enabling faster turnaround times and more reliable results. This trend has boosted the role of laboratory testing from routine diagnostics to an essential tool for early disease detection and comprehensive patient management, reinforcing its importance in improving overall healthcare outcomes.

The U.S. clinical laboratory tests market is driven by the rising focus on personalized medicine, which requires advanced diagnostics tailored to individual patient profiles. Laboratory testing has a central role in identifying biomarkers, genetic predispositions, and treatment responses, thereby supporting targeted therapies. The growing adoption of precision healthcare is fueling demand for specialized and vast tests that go beyond routine diagnostics. This shift towards patient-centric solutions is reinforcing the strategic importance of laboratory services in delivering effective, customized medical care.

U.S. Clinical Laboratory Tests Market Report Highlights

In terms of type, the HbA1c segment held a 16.42% revenue share in 2024, driven by growing diabetes rates and an increased focus on long-term blood sugar management.

Based on end use, the primary clinics segment is projected to grow at an 8.7% CAGR, fueled by the shift toward decentralized care and improved local diagnostic access.

A few global key market players include Abbott Laboratories; ARUP Laboratories; BioReference Laboratories, Inc.; Charles River Laboratories; Genoptix, Inc.; LabCorp; Mayo Clinic Laboratories; NeoGenomics Laboratories, Inc.; OPKO Health, Inc.; and Quest Diagnostics.

Polaris Market Research has segmented the market report on the basis of type, end use:

By Type Outlook (Revenue, USD Billion, 2020–2034)

Complete Blood Count

HGB/HCT

Basic Metabolic Panel

BUN Creatinine Tests

Electrolytes Testing

HbA1c Tests

Comprehensive Metabolic Panel

Liver Panel

Renal Panel

Lipid Panel

By End Use Outlook (Revenue, USD Billion, 2020–2034)

Central Laboratories

Primary Clinics Show more